UNICA IRIS Institutional Research Information System

PISANU, CLAUDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 151.713
NA - Nord America 7.336
AS - Asia 3.057
SA - Sud America 802
AF - Africa 107
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 1
Totale 163.046
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 149.719
US - Stati Uniti d'America 7.157
SG - Singapore 1.168
CN - Cina 1.064
BR - Brasile 671
SE - Svezia 528
DE - Germania 304
GB - Regno Unito 278
VN - Vietnam 259
NL - Olanda 174
FI - Finlandia 141
UA - Ucraina 129
CA - Canada 106
FR - Francia 103
HK - Hong Kong 99
IN - India 85
KR - Corea 78
ES - Italia 66
AR - Argentina 58
MX - Messico 54
JP - Giappone 52
AT - Austria 47
PL - Polonia 44
BD - Bangladesh 37
BE - Belgio 35
TR - Turchia 35
ZA - Sudafrica 35
MA - Marocco 33
RU - Federazione Russa 28
EC - Ecuador 27
AU - Australia 26
NO - Norvegia 23
IR - Iran 21
ID - Indonesia 18
CZ - Repubblica Ceca 17
IE - Irlanda 16
IQ - Iraq 16
DK - Danimarca 14
UZ - Uzbekistan 14
SA - Arabia Saudita 13
CL - Cile 11
CO - Colombia 11
PK - Pakistan 11
TW - Taiwan 11
AE - Emirati Arabi Uniti 10
EG - Egitto 10
IL - Israele 9
LT - Lituania 9
VE - Venezuela 9
KZ - Kazakistan 8
PT - Portogallo 8
AZ - Azerbaigian 7
JO - Giordania 7
KE - Kenya 7
PH - Filippine 7
DZ - Algeria 6
PY - Paraguay 6
CH - Svizzera 5
KG - Kirghizistan 5
TN - Tunisia 5
CI - Costa d'Avorio 4
GE - Georgia 4
MY - Malesia 4
NZ - Nuova Zelanda 4
OM - Oman 4
PE - Perù 4
RS - Serbia 4
AL - Albania 3
AM - Armenia 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
KW - Kuwait 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BG - Bulgaria 2
BO - Bolivia 2
HN - Honduras 2
HR - Croazia 2
IS - Islanda 2
MG - Madagascar 2
NI - Nicaragua 2
RO - Romania 2
SN - Senegal 2
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
EU - Europa 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
IM - Isola di Man 1
KH - Cambogia 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
Totale 163.040
Salva come PNG Salva come JPEG
Città #
Cagliari 144.796
Uta 4.411
Ashburn 794
Dallas 774
Fairfield 721
Singapore 492
Chandler 379
Woodbridge 340
Boardman 319
Houston 319
Seattle 287
New York 280
Nyköping 260
Beijing 237
Cambridge 221
Wilmington 221
Los Angeles 180
Ann Arbor 177
Santa Clara 136
Hefei 123
Shanghai 115
Boston 104
The Dalles 90
Dearborn 88
Hong Kong 85
Helsinki 76
Seoul 75
São Paulo 72
Ho Chi Minh City 70
Munich 70
Jacksonville 69
Dong Ket 60
Buffalo 59
Cardiff 56
Nieuwegein 54
Rome 51
Tokyo 43
Hanoi 42
Nuremberg 42
Atlanta 40
Chicago 39
Montreal 39
San Diego 39
Redondo Beach 38
London 37
Warsaw 36
Nanjing 35
Frankfurt am Main 33
Brussels 31
Johannesburg 29
Denver 28
Vienna 28
Brooklyn 27
Council Bluffs 27
Redwood City 27
Amsterdam 26
Casablanca 26
Stockholm 25
Poplar 24
San Francisco 24
Chennai 22
Milan 22
Turku 22
Lappeenranta 21
Mexico City 21
Norwalk 21
Orem 21
Oslo 21
Phoenix 21
Guangzhou 20
Rio de Janeiro 20
Tianjin 18
Nanchang 17
Rotterdam 17
Toronto 17
Shenyang 16
Aurora 15
Belo Horizonte 15
Swansea 15
Ankara 14
Changsha 14
Jiaxing 13
Pune 13
Selargius 12
Shenzhen 12
Tashkent 12
Brasília 11
Da Nang 11
Portsmouth 11
San Mateo 11
Brno 10
Düsseldorf 10
Guayaquil 10
Barendrecht 9
Biên Hòa 9
Buenos Aires 9
Curitiba 9
Falls Church 9
Hangzhou 9
Hebei 9
Totale 158.035
Salva come PNG Salva come JPEG
Nome #
Leukocyte telomere length positively correlates with duration of lithium treatment in bipolar disorder patients 4.309
Count of “dark telomere” on the track of a biomarker for lithium treatment in bipolar disorder 4.221
Odor identification performance in idiopathic Parkinson’s disease is associated with gender and the genetic variability of the olfactory binding protein 3.626
Major depression subtypes are differentially associated with migraine subtype, prevalence and severity 3.595
Whole Genome Expression Analyses of miRNAs and mRNAs Suggest the Involvement of miR-320a and miR-155-3p and their Targeted Genes in Lithium Response in Bipolar Disorder 3.530
A multidisciplinary approach to mental illness: Do inflammation, telomere length and microbiota form a loop? A protocol for a cross-sectional study on the complex relationship between inflammation, telomere length, gut microbiota and psychiatric disorders 3.467
Challenges and Future Prospects of Precision Medicine in Psychiatry 3.397
Differences in telomere length between patients with bipolar disorder and controls are influenced by lithium treatment 3.097
Evidence towards RNA Binding Motif (RNP1, RRM) Protein 3 (RBM3) as a Potential Biomarker of Lithium Response in Bipolar Disorder Patients 3.002
Preliminary transcriptome analysis in lymphoblasts from cluster headache and bipolar disorder patients implicates dysregulation of circadian and serotonergic genes 2.985
Convergent analysis of genome-wide genotyping and transcriptomic data suggests association of zinc finger genes with lithium response in bipolar disorder 2.976
Exploring the role of gut microbiota in major depressive disorder and in treatment resistance to antidepressants 2.945
Circulating antithyroid antibodies contribute to the decrease of glomerular filtration rate in lithium-treated patients: a longitudinal study 2.944
Exposure and duration of lithium treatment affect leukocyte telomere length in bipolar disorder patients 2.860
Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications 2.826
HDAC3 role in medication consumption in medication overuse headache patients: a pilot study 2.797
Involvement of core clock genes in lithium response 2.776
Anterior pituitary autoantibodies in patients with type 1 diabetes mellitus: methodological problems and clinical correlations 2.667
Understanding the molecular mechanisms underlying mood stabilizer treatments in bipolar disorder: potential involvement of epigenetics 2.643
Investigating the relationship between melatonin levels, melatonin system, microbiota composition and bipolar disorder psychopathology across the different phases of the disease 2.641
C9ORF72 repeat expansion and bipolar disorder–is there a link? No mutation detected in a Sardinian cohort of patients with bipolar disorder 2.633
Increasing engagement in pharmacology and pharmacogenetics education using games and online resources: the PharmacoloGenius mobile app 2.610
Interstitial lung disease induced by fluoxetine: Systematic review of literature and analysis of Vigiaccess, Eudravigilance and a national pharmacovigilance database. 2.565
Prediction of Lithium Response using Clinical Data 2.449
Sex differences in the response to opioids for pain relief: A systematic review and meta-analysis 2.439
High leptin levels are associated with migraine with aura 2.437
Pharmacogenomics of bipolar disorder 2.357
No association of endocannabinoid genes with bipolar disorder or lithium response in a Sardinian sample 2.327
Lithium pharmacogenetics: Where do we stand? 2.235
Mood Disorders, Accelerated Aging, and Inflammation: Is the Link Hidden in Telomeres? 2.189
Exemplar scoring identifies genetically separable phenotypes of lithium responsive bipolar disorder 2.143
null 2.132
Thyroid and renal tumors in patients treated with long-term lithium: case series from a lithium clinic, review of the literature and international pharmacovigilance reports 2.065
An examination of the quality and performance of the Alda scale for classifying lithium response phenotypes 1.973
Characterisation of age and polarity at onset in bipolar disorder 1.972
Efficacia dei farmaci per l’alcolismo: il ruolo della genetica 1.960
MicroRNA expression profiling of lymphoblasts from bipolar disorder patients who died by suicide, pathway analysis and integration with postmortem brain findings 1.900
Clinical, genetic, and brain imaging predictors of risk for bipolar disorder in high-risk individuals 1.864
Lithium pharmacogenetics 1.834
A genetic risk score is differentially associated with migraine with and without aura 1.817
Evidence that genes involved in hedgehog signaling are associated with both bipolar disorder and high BMI 1.695
Zinc finger proteins in psychiatric disorders and response to psychotropic medications 1.639
Leukocyte telomere length is reduced in patients with major depressive disorder 1.630
Prediction of lithium response using genomic data 1.602
Presenting Psychiatric and Neurological Symptoms and Signs of Brain Tumors before Diagnosis: A Systematic Review 1.584
Treatment-Resistant Schizophrenia: Insights From Genetic Studies and Machine Learning Approaches 1.582
null 1.572
We are not alone in our body: insights into the involvement of microbiota in the etiopathogenesis and pharmacology of mental illness 1.490
Recent trends on the role of epigenomics, metabolomics and noncoding RNAs in rationalizing mood stabilizing treatment 1.474
PharmacoloGenius: Development of a mobile application to engage in pharmacology 1.426
Telomere length in bipolar disorder and lithium response 1.280
Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients 1.210
Protocol for a pharmacogenetic study of antidepressants: characterization of drug-metabolizing profiles of cytochromes CYP2D6 and CYP2C19 in a Sardinian population of patients with major depressive disorder 1.209
Investigation of genetic loci shared between bipolar disorder and risk-taking propensity: potential implications for pharmacological interventions 1.197
A pharmacogenetic risk score for the evaluation of major depression severity under treatment with antidepressants 1.163
The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine 1.159
null 1.156
Assessment of the pharmacogenomics educational environment in southeast europe 1.151
Association of Attention-Deficit/Hyperactivity Disorder and Depression Polygenic Scores with Lithium Response: A Consortium for Lithium Genetics Study 1.134
HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders 966
A genome-wide association study of antidepressant-induced mania 926
Gender Differences among Sardinians with Alcohol Use Disorder 894
Sex differences in alcohol use disorder 786
Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients 783
The Xs and Y response to opioids in acute and chronic pain 767
Sex differences in substance use disorders: focus on side effects 740
Involvement of gut microbiota in schizophrenia and treatment resistance to antipsychotics 726
Investigating Shared Genetic Bases between Psychiatric Disorders, Cardiometabolic and Sleep Traits Using K-Means Clustering and Local Genetic Correlation Analysis 725
Cost–utility analysis of pharmacogenetic testing based on CYP2C19 or CYP2D6 in major depressive disorder: assessing the drivers of different cost-effectiveness levels from an Italian societal perspective 719
Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders 715
Investigation of Genetic Variants Associated with Tryptophan Metabolite Levels via Serotonin and Kynurenine Pathways in Patients with Bipolar Disorder 708
Association between migraine prevalence, treatment with proton-pump inhibitors and CYP2C19 phenotypes in UK Biobank 704
Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: machine learning approach 677
Correction: Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients (Translational Psychiatry, (2021), 11, 1, (606), 10.1038/s41398-021-01702-2) 675
Probing the Association between Cognition, Suicidal Behavior and Tryptophan Metabolism in a Sample of Individuals Living with Bipolar Disorder: A Secondary Analysis 663
Is Poor Lithium Response in Individuals with Bipolar Disorder Associated with Increased Degradation of Tryptophan along the Kynurenine Pathway? Results of an Exploratory Study 658
Association of polygenic score and the involvement of cholinergic and glutamatergic pathways with lithium treatment response in patients with bipolar disorder 649
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores 634
Investigating the role of leukocyte telomere length in treatment-resistant depression and in response to electroconvulsive therapy 625
Pharmacokinetic Markers of Clinical Outcomes in Severe Mental Illness: A Systematic Review 610
Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review 607
Effect of Lithium on gene expression modulation 603
Genetic and Epigenetic Markers of Lithium Response 599
An integrated precision medicine approach in major depressive disorder: a study protocol to create a new algorithm for the prediction of treatment response 596
Dissecting the genetic overlap between severe mental disorders and markers of cellular aging: Identification of pleiotropic genes and druggable targets 578
Recommendations for pharmacotranscriptomic profiling of drug response in CNS disorders 570
Analysis on in vitro effect of lithium on telomere length in lymphoblastoid cell lines from bipolar disorder patients with different clinical response to long-term lithium treatment 547
Migraine and gastrointestinal disorders in middle and old age: A UK Biobank study 520
An analysis-ready and quality controlled resource for pediatric brain white-matter research 488
Summaries of plenary, symposia, and oral sessions at the XXII World Congress of Psychiatric Genetics, Copenhagen, Denmark, 12-16 October 2014 486
High efficacy of onabotulinumtoxinA treatment in patients with comorbid migraine and depression: a meta-analysis 461
Melatonin MT1 receptors as a target for the psychopharmacology of bipolar disorder: A translational study 449
Towards precision medicine in psychiatry: investigating the contribution of cellular aging, pleiotropy and gender differences in psychiatric disorders and pharmacological response 448
Plasma stearoyl-coA desaturase activity indices and bile acid concentrations after a low-fat meal: Association with a genetic variant in the FTO gene 427
Symptomatic remission and recovery in major psychosis: Is there a role for BDNF? A secondary analysis of the LABSP cohort data 422
New insights into the genetic etiology of Alzheimer's disease and related dementias 421
Squamous-cell carcinoma of the tongue following therapy of rheumatoid arthritis with abatacept 413
NAFLD is associated with methylation shifts with relevance for the expression of genes involved in lipoprotein particle composition 394
A Pilot Interaction Analysis of Gut Microbiota and Peripheral Markers of Aging in Severe Psychiatric Disorders: A Role for Lachnoclostridium? 356
Erratum: Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: Machine learning approach (The British Journal of Psychiatry (2022) (1–10) DOI: 10.1192/bjp.2022.28) 342
Totale 158.635
Salva come PNG Salva come JPEG
Categoria #
all - tutte 207.730
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 207.730
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118.523 0 0 0 0 0 4.698 2.682 2.666 1.377 2.741 2.720 1.639
2021/202210.999 1.450 652 510 1.016 990 707 574 508 1.262 1.197 1.204 929
2022/202316.802 960 2.313 2.452 1.529 1.304 1.617 848 1.042 1.211 1.248 1.470 808
2023/202416.375 770 611 612 1.037 1.419 2.565 2.311 1.197 835 1.075 1.958 1.985
2024/202538.024 10.322 11.152 3.920 3.963 2.061 2.347 2.445 163 396 410 319 526
2025/20265.562 940 614 1.489 1.289 997 233 0 0 0 0 0 0
Totale 163.636